LCM
PFE icon

LCM Capital Management’s Pfizer PFE Stock Holding History

LCM Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$348K Buy
14,441
+334
+2% +$8.74K 0.15% 75
2026
Q1 		$396K Buy
14,107
+110
+0.8% +$2.93K 0.2% 64
2025
Q4 		$349K Sell
13,997
-1,019
-7% -$25.7K 0.17% 71
2025
Q3 		$383K Sell
15,016
-123
-0.8% -$3.04K 0.18% 65
2025
Q2 		$367K Sell
15,139
-3,849
-20% -$89.8K 0.19% 68
2025
Q1 		$481K Sell
18,988
-336
-2% -$8.79K 0.28% 51
2024
Q4 		$513K Sell
19,324
-166
-0.9% -$4.5K 0.29% 50
2024
Q3 		$564K Buy
19,490
+31
+0.2% +$904 0.32% 45
2024
Q2 		$544K Sell
19,459
-29
-0.1% -$798 0.34% 45
2024
Q1 		$541K Sell
19,488
-144
-0.7% -$4K 0.35% 44
2023
Q4 		$565K Sell
19,632
-187
-0.9% -$5.65K 0.41% 42
2023
Q3 		$657K Buy
19,819
+123
+0.6% +$4.35K 0.54% 35
2023
Q2 		$722K Buy
19,696
+301
+2% +$11.7K 0.59% 34
2023
Q1 		$791K Buy
19,395
+621
+3% +$26.8K 0.69% 26
2022
Q4 		$962K Buy
18,774
+9
+0% +$431 0.94% 19
2022
Q3 		$821K Sell
18,765
-52
-0.3% -$2.53K 0.87% 18
2022
Q2 		$987K Sell
18,817
-86
-0.5% -$4.38K 0.97% 17
2022
Q1 		$979K Buy
18,903
+131
+0.7% +$6.8K 0.79% 21
2021
Q4 		$1.11M Buy
18,772
+510
+3% +$25.3K 0.86% 20
2021
Q3 		$785K Sell
18,262
-256
-1% -$11.3K 0.66% 26
2021
Q2 		$725K Buy
18,518
+3,742
+25% +$146K 0.6% 32
2021
Q1 		$535K Sell
14,776
-427
-3% -$15.2K 0.48% 41
2020
Q4 		$559K Buy
+15,203
New +$558K 0.53% 36

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LCM Capital Management's PFE Position: Q2 2026 in Review

LCM Capital Management increased its Pfizer (PFE) stake by 2.4% in Q2 2026, buying an estimated $8.74K and bringing the position to 14,441 shares worth $348K. The position accounts for 0.15% of the portfolio, ranked #75.

LCM Capital Management first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.11M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • LCM Capital Management held 14,441 shares of Pfizer worth $348K as of Q2 2026.
  • LCM Capital Management bought 334 Pfizer shares in Q2 2026, an estimated $8.74K.
  • Pfizer made up 0.15% of LCM Capital Management's portfolio in Q2 2026, its #75 holding.
  • LCM Capital Management first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • LCM Capital Management's Pfizer position peaked at $1.11M in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on LCM Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.